MaxCyte (NASDAQ:MXCT) Price Target Lowered to $9.00 at Stifel Nicolaus
MaxCyte (NASDAQ:MXCT – Free Report) had its price objective cut by Stifel Nicolaus from $11.00 to $9.00 in a report released on Wednesday morning,Benzinga reports. They currently have a buy rating on the stock. MaxCyte Stock Up 7.5 % MaxCyte stock opened at $3.29 on Wednesday. MaxCyte has a 52 week low of $2.76 and […]
